{"analyses":[{"ciNumSides":"TWO_SIDED","groupDescription":"Analyze whether the mean fold increase from the baseline to the peak time change was significant or not.","groupIds":["OG000"],"nonInferiorityType":"SUPERIORITY_OR_OTHER_LEGACY","pValue":"0.023","pValueComment":"P values less than 0.05 are considered statistically significant in this study.","statisticalMethod":"t-test, 2 sided"},{"ciNumSides":"TWO_SIDED","groupDescription":"Analyze whether the mean fold increase from the baseline to the peak time change was significant or not.","groupIds":["OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER_LEGACY","pValue":"0.038","pValueComment":"P values less than 0.05 are considered statistically significant in this study.","statisticalMethod":"t-test, 2 sided"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"5.9","value":"7.0"},{"groupId":"OG001","spread":"6.1","value":"6.1"},{"groupId":"OG002","spread":"5.9","value":"6.4"}]}],"title":"Fold increase (3 hours after infusion)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"7.2","value":"7.8"},{"groupId":"OG001","spread":"10.4","value":"7.8"},{"groupId":"OG002","spread":"9.1","value":"7.8"}]}],"title":"Fold increase (6 hours after infusion)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"7.5","value":"9.3"},{"groupId":"OG001","spread":"8.9","value":"10.3"},{"groupId":"OG002","spread":"8.4","value":"10.0"}]}],"title":"Fold increase (Maximum increase)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"19"}],"units":"Participants"}],"dispersionType":"Standard Deviation","groups":[{"description":"7 patients with MM were enrolled.","id":"OG000","title":"Multiple Myeloma (MM)"},{"description":"10 patients and 2 patients with NHL and HD were enrolled, respectively.","id":"OG001","title":"Non-Hodgkin Lymphoma (NHL) + Hodgkin Disease (HD)"},{"description":"All patents = MM + NHL + HD","id":"OG002","title":"All Patients"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Baseline, 3 hours and 6 hours after infusion","title":"Fold Increase of Circulating CD34+ Cell Counts in Peripheral Blood.","type":"SECONDARY","unitOfMeasure":"fold"}